SCHEMBL8665880

SCHEMBL8665880

CCCCN(CC(F)(F)F)C(=O)C1c2ccccc2-c2cccc(N3CCC(NC(=O)c4ccccc4)C3)c21

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ UTS2R Q9UKP6 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ MTNR1A P48039 6/20 0.37
▸ MTNR1B P49286 6/20 0.37
▸ DRD2 P14416 3/20 0.37
▸ DRD4 P21917 3/20 0.37
▸ CARM1 Q86X55 1/20 0.36
▸ PRMT6 Q96LA8 1/20 0.36
▸ MCHR1 Q99705 1/20 0.35
▸ AKT1 P31749 1/20 0.35
▸ CTSL P07711 1/20 0.35
▸ CTSB P07858 1/20 0.35
▸ CTSK P43235 1/20 0.35
▸ CKS1B P61024 1/20 0.35
▸ SKP1 P63208 1/20 0.35
▸ SKP2 Q13309 1/20 0.35
▸ CHRM1 P11229 2/20 0.35
▸ NAMPT P43490 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8666092 0.98 UTS2R (0.39) UTS2RNPSR1MTNR1AMTNR1BDRD2
SCHEMBL8485533 0.95 NPSR1 (0.42) UTS2RNPSR1DRD2CARM1PRMT6
SCHEMBL8501233 0.94 NPSR1 (0.36) UTS2RNPSR1DRD2DRD4CHRM1
SCHEMBL8484454 0.93 NPSR1 (0.42) UTS2RNPSR1DRD2CARM1PRMT6
SCHEMBL8501048 0.91 NPSR1 (0.35) UTS2RNPSR1CHRM1
SCHEMBL8669685 0.91 NPSR1 (0.42) UTS2RNPSR1MTNR1AMTNR1BDRD2
SCHEMBL8664869 0.89 SMPD3 (0.38) MTNR1AMTNR1BCKS1BSKP1SKP2
SCHEMBL8665477 0.89 DRD2 (0.37) UTS2RNPSR1DRD2DRD4CARM1
SCHEMBL8665515 0.89 CCR3 (0.41) NPSR1MTNR1AMTNR1BDRD2
SCHEMBL8668033 0.88 CCR3 (0.41) UTS2RNPSR1DRD2DRD4MCHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5827875-A PYRROLIDINE DERIVATIVES; ANTIATHEROSCLEROSIS AGENTS BRISTOL-MYERS SQUIBB COMPANY (US) 1998-10-27 — — US disclosed
Send feedback